What you should know:
1. Alphatec’s U.S. revenues were $28.1 million, up 34 percent year over year.
2. Operating expenses increased 33 percent to $31.5 million, up from $23.7 million year over year.
3. Alphatec posted a quarterly loss of $11.6 million, up from $7.53 million from the previous quarter last year.
4. The company’s non-adjusted EBITDA was negative $3.2 million, compared to 2018’s negative $1.4 million.
5. Despite the losses, Alphatec touted the closure of an equity offering and the launch of five new devices.
6. The company updated its full-year U.S. product revenue expectations to $105 million to $107 million from $100 million to $104 million.
More articles on orthopedic devices:
Orthofix reports $40.5M loss & more: 7 device company notes
SeaSpine posts $39.9M Q3 revenue
Stryker Q3 net sales hit $3.6B; spine sales up 35%
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.